November 1, 2022
NOT-HL-22-056 - Notice of Change in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"
PAR-22-194 - NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to alert potential applicants to the addition of AIDS application due dates and change in expiration date for PAR-22-194, "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)". Changes are shown in bold italics below.
Part 1. Overview Information
Key Dates
Current dates:
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 18, 2022 | October 18, 2022 | Not Applicable | March 1, 2023 | May 1, 2023 | July 1, 2023 |
| October 17, 2023 | October 17, 2023 | Not Applicable | March 1, 2024 | May 1, 2024 | July 1, 2024 |
| October 17, 2024 | October 17, 2024 | Not Applicable | March 1, 2025 | May 1, 2025 | July 1, 2025 |
Expiration Date: October 18, 2024
Revised dates (in bold italics):
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 18, 2022 | October 18, 2022 | January 7, 2023 | March 1, 2023 | May 1, 2023 | July 1, 2023 |
| October 17, 2023 | October 17, 2023 | January 7, 2024 | March 1, 2024 | May 1, 2024 | July 1, 2024 |
| October 17, 2024 | October 17, 2024 | January 7, 2025 | March 1, 2025 | May 1, 2025 | July 1, 2025 |
Expiration Date: January 8, 2025
All other aspects of this FOA remain unchanged.
Scientific/Research Contact(s)
Pankaj Qasba, Ph.D.
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0070
E-mail: [email protected]
Jane Ye, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301 480-7447
Email: [email protected]
Ye Yan, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-6779
Email: [email protected]
Shimian Zou, Ph.D. (AIDS Application Inquiries)
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8301
Email: [email protected]
and Human Services (HHS)
